1-Methylhistamine dihydrochloride,
6481-48-7,
2-(1-Methyl-1H-imidazol-4-yl)ethanamine dihydrochloride,
MFCD00037000,
2-(1-methyl-1H-imidazol-4-yl)ethan-1-amine dihydrochloride,
1-Methyl-4-(beta-aminoethyl)imidazole dihydrochloride,
1-Methyl-4-[beta-aminoethyl]imidazole dihydrochloride,
EU-0100757,
1-METHYLHISTAMINE 2HCL,
SCHEMBL1320841,
CHEMBL1487156,
AGXVEALMQHTMSW-UHFFFAOYSA-N,
KS-000019WB,
Tox21_500757,
2-(1-Methylimidazole-4-yl)ethanamine,
AKOS016367671,
CCG-222061,
LP00757,
MCULE-1498707236,
NCGC00094097-01,
NCGC00261442-01,
NS-01990,
ST085498,
AX8320530,
CS-0046885,
C-0263,
M 4910,
SR-01000075290,
1-Methyl-4-(|A-aminoethyl)imidazole dihydrochloride,
1-methyl-4-(2-aminoethyl)imidazole dihydrochloride,
2-(1-methylimidazol-4-yl)ethanamine;dihydrochloride,
SR-01000075290-1,
1-Methylhistamine dihydrochloride, >=98% (TLC), powder,
[2-(1-methyl-1H-imidazol-4-yl)ethyl]amine dihydrochloride,
2(1-Methyl-1H-imidazol-4-yl)-ethylamine bis hydrochloride,
N-Methylhistamine dihydrochloride,
CID11957601,
2-(1-methylimidazol-4-yl)ethanamine dihydrochloride,
1H-Imidazole-4-ethanamine, 1-methyl-, dihydrochloride,
Imidazole, 4-(2-aminoethyl)-1-methyl-, dihydrochloride,
501-75-7,